Your shopping cart is currently empty

RS-601 is a potent dual leukotriene D4/thromboxane A2 inhibitor that inhibits antigen-induced airway hyperresponsiveness (AHR) and shows asthmatic effects in a guinea pig model of asthma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $700 | - | In Stock | |
| 5 mg | $1,800 | - | In Stock |
| Description | RS-601 is a potent dual leukotriene D4/thromboxane A2 inhibitor that inhibits antigen-induced airway hyperresponsiveness (AHR) and shows asthmatic effects in a guinea pig model of asthma. |
| In vivo | In a dose-dependent fashion in guinea pigs, RS-601 (1-10 mg/kg) clearly inhibits the bronchoconstriction induced by intravenous administration of U-46619 and LTD4. Similarly, RS-1452 (10 mg/kg) significantly inhibits U-46619-induced bronchoconstriction. At a dose of 10 mg/kg, RS-601 significantly inhibits the late-phase response and LPS-induced AHR. However, it does not affect biphasic bronchial responses. Additionally, RS-601 (3 and 10 mg/kg) clearly inhibits the AHR[1]. |
| Molecular Weight | 511.48 |
| Formula | C22H23F6NO4S |
| Cas No. | 207987-59-5 |
| Smiles | O=C(O)CCCC1=CC=C(C=C1)C(NS(=O)(=O)C2=CC=C(F)C=C2)CCCC(F)(F)C(F)(F)F |
| Relative Density. | 1.360 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.